Regeneron Pharmaceuticals, Inc.

Industry

  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Drug Discovery Technologies
    • Large Molecule
      • Antibodies
  • Pharmaceuticals

Other Names/Subsidiaries

  • Checkmate Pharmaceuticals
  • Decibel Therapeutics
  • Regeneron Genetics Center LLC (RGC)
See more in Biomedtracker

Latest on Regeneron Pharmaceuticals, Inc.

Pink Sheet

Another Regeneron CRL Prompts Regulatory Operations Questions

 
• By Alaric DeArment

Another complete response letter for Regeneron Pharmaceuticals ' Eylea HD (afilbercept 8 mg) prefilled syringe could delay the product’s expected launch, but also raises questions about the company’s

In Vivo

Top-Selling Drugs 2024: Keytruda, Ozempic And Dupixent Dominate

 
• By Eleanor Malone

Strong growth across multiple cancer indications as well as price rises saw Merck & Co’s PD-1 inhibitor Keytruda (pembrolizumab) increase its revenues by 18% in 2024, putting it more than $12bn ah

Scrip

Another CRL Prompts Questions About Regeneron’s Regulatory Operations

 
• By Alaric DeArment

Regeneron Pharmaceuticals found itself on the defensive on its first quarter sales and earnings call as the firm provided some details on its latest complete response letter (CRL) from the US Food and

Scrip

Stock Watch: Sanofi, Merck Open Windows Into Geopolitical Risks

 
• By Andy Smith

Vaccine Growth Vs. Recent Dollar Weakness The week before Sanofi reported its first-quarter earnings, Johnson & Johnson (J&J) provided some insight into the impact of import tariffs and the as